Skip to main content
Erschienen in: Annals of Surgical Oncology 9/2018

13.07.2018 | Gastrointestinal Oncology

Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach

verfasst von: Lisa Martin, MSc, RD, Jessica Hopkins, MD, Georgios Malietzis, PhD, MD, J. T. Jenkins, MD, Michael B. Sawyer, MD, Ron Brisebois, MD, Anthony MacLean, MD, Gregg Nelson, PhD, MD, Leah Gramlich, MD, Vickie E. Baracos, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Sarcopenia, visceral obesity (VO), and reduced muscle radiodensity (myosteatosis) are suggested risk factors for postoperative morbidity in colorectal cancer (CRC), but usually are not concurrently assessed. Published thresholds used to define these features are not CRC-specific and are defined in relation to mortality, not postoperative outcomes. This study aimed to evaluate body composition in relation to length of hospital stay (LOS) and postoperative outcomes.

Methods

Pre-surgical computed tomography (CT) images were assessed for total area and radiodensity of skeletal muscle and visceral adipose tissue in a pooled Canadian and UK cohort (n = 2100). Sex- and age-specific values for these features were calculated. For 1139 of 2100 patients, LOS data were available, and sex- and age-specific thresholds for sarcopenia, myosteatosis, and VO were defined on the basis of LOS. Association of CT-defined features with LOS and readmissions was explored using negative binomial and logistic regression models, respectively.

Results

In the multivariable analysis, the predictors of LOS (P < 0.001) were age, surgical approach, major complications (incidence rate ratio [IRR] 2.42; 95% confidence interval [CI] 2.18–2.68), study cohort, and three body composition profiles characterized by myosteatosis combined with either sarcopenia (IRR, 1.27; 95% CI 1.12–1.43) or VO (IRR, 1.25; 95% CI 1.10–1.42), and myosteatosis combined with both sarcopenia and VO (IRR, 1.58; 95% CI 1.29–1.93). In the multivariable analysis, risk of readmission was associated with VO alone (odds ratio [OR] 2.66; 95% CI 1.18–6.00); P = 0.018), VO combined with myosteatosis (OR, 2.72; 95% CI 1.36–5.46; P = 0.005), or VO combined with myosteatosis and sarcopenia (OR, 2.98; 95% CI 1.06–5.46; P = 0.038). Importantly, the effect of body composition profiles on LOS and readmission was independent of major complications.

Conclusion

The findings showed that CT-defined multidimensional body habitus is independently associated with LOS and hospital readmission.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Cakir H, Heus C, van der Ploeg TJ, Houdijk AP. Visceral obesity determined by CT scan and outcomes after colorectal surgery; a systematic review and meta-analysis. Int J Colorectal Dis. 2015;30:875–82.CrossRefPubMed Cakir H, Heus C, van der Ploeg TJ, Houdijk AP. Visceral obesity determined by CT scan and outcomes after colorectal surgery; a systematic review and meta-analysis. Int J Colorectal Dis. 2015;30:875–82.CrossRefPubMed
2.
Zurück zum Zitat Kazemi-Bajestani SM, Mazurak VC, Baracos V. Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes. Semin Cell Dev Biol. 2016;54:2–10.CrossRefPubMed Kazemi-Bajestani SM, Mazurak VC, Baracos V. Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes. Semin Cell Dev Biol. 2016;54:2–10.CrossRefPubMed
3.
Zurück zum Zitat Malietzis G, Aziz O, Bagnall NM, Johns N, Fearon KC, Jenkins JT. The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: a systematic review. Eur J Surg Oncol. 2015;41:186–96.CrossRefPubMed Malietzis G, Aziz O, Bagnall NM, Johns N, Fearon KC, Jenkins JT. The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: a systematic review. Eur J Surg Oncol. 2015;41:186–96.CrossRefPubMed
4.
Zurück zum Zitat Mei KL, Batsis JA, Mills JB, Holubar SD. Sarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery? Periop Med London. 2016;5:30.CrossRef Mei KL, Batsis JA, Mills JB, Holubar SD. Sarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery? Periop Med London. 2016;5:30.CrossRef
5.
Zurück zum Zitat Martin L, Birdsell L, MacDonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539–47.CrossRefPubMed Martin L, Birdsell L, MacDonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539–47.CrossRefPubMed
6.
Zurück zum Zitat Yip C, Dinkel C, Mahajan A, Siddique M, Cook GJ, Goh V. Imaging body composition in cancer patients: visceral obesity, sarcopenia, and sarcopenic obesity may impact on clinical outcome. Insights Imaging. 2015;6:489–97.CrossRefPubMedPubMedCentral Yip C, Dinkel C, Mahajan A, Siddique M, Cook GJ, Goh V. Imaging body composition in cancer patients: visceral obesity, sarcopenia, and sarcopenic obesity may impact on clinical outcome. Insights Imaging. 2015;6:489–97.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Boer BC, de Graaff F, Brusse-Keizer M, et al. Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancer. Int J Colorectal Dis. 2016;31:1117–24.CrossRefPubMed Boer BC, de Graaff F, Brusse-Keizer M, et al. Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancer. Int J Colorectal Dis. 2016;31:1117–24.CrossRefPubMed
8.
Zurück zum Zitat Lodewick TM, van Nijnatten TJ, van Dam RM, et al. Are sarcopenia, obesity, and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases? HPB Oxford. 2015;17:438–46.CrossRefPubMed Lodewick TM, van Nijnatten TJ, van Dam RM, et al. Are sarcopenia, obesity, and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases? HPB Oxford. 2015;17:438–46.CrossRefPubMed
9.
Zurück zum Zitat Malietzis G, Currie AC, Athanasiou T, et al. Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg. 2016;103:572–80.CrossRefPubMed Malietzis G, Currie AC, Athanasiou T, et al. Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg. 2016;103:572–80.CrossRefPubMed
10.
Zurück zum Zitat Moon HG, Ju YT, Jeong CY, et al. Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol. 2008;15:1918–22.CrossRefPubMed Moon HG, Ju YT, Jeong CY, et al. Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol. 2008;15:1918–22.CrossRefPubMed
11.
Zurück zum Zitat Ouchi A, Asano M, Aono K, Watanabe T, Oya S. Laparoscopic colorectal resection in patients with sarcopenia: a retrospective case-control study. J Laparoendosc Adv Surg Tech A. 2016;26:366–70.CrossRefPubMed Ouchi A, Asano M, Aono K, Watanabe T, Oya S. Laparoscopic colorectal resection in patients with sarcopenia: a retrospective case-control study. J Laparoendosc Adv Surg Tech A. 2016;26:366–70.CrossRefPubMed
12.
Zurück zum Zitat Ozoya OO, Siegel EM, Srikumar T, Bloomer AM, DeRenzis A, Shibata DA-OhooX. Quantitative assessment of visceral obesity and postoperative colon cancer outcomes. J Gastrointest Surg. 2017;21:534–42.CrossRefPubMedPubMedCentral Ozoya OO, Siegel EM, Srikumar T, Bloomer AM, DeRenzis A, Shibata DA-OhooX. Quantitative assessment of visceral obesity and postoperative colon cancer outcomes. J Gastrointest Surg. 2017;21:534–42.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Pedziwiatr M, Pisarska M, Major P, et al. Laparoscopic colorectal cancer surgery combined with enhanced recovery after surgery protocol (ERAS) reduces the negative impact of sarcopenia on short-term outcomes. Eur J Surg Oncol. 2016;42:779–87.CrossRefPubMed Pedziwiatr M, Pisarska M, Major P, et al. Laparoscopic colorectal cancer surgery combined with enhanced recovery after surgery protocol (ERAS) reduces the negative impact of sarcopenia on short-term outcomes. Eur J Surg Oncol. 2016;42:779–87.CrossRefPubMed
14.
Zurück zum Zitat Sabel MS, Terjimanian M, Conlon AS, et al. Analytic morphometric assessment of patients undergoing colectomy for colon cancer. J Surg Oncol. 2013;108:169–75.CrossRefPubMed Sabel MS, Terjimanian M, Conlon AS, et al. Analytic morphometric assessment of patients undergoing colectomy for colon cancer. J Surg Oncol. 2013;108:169–75.CrossRefPubMed
15.
Zurück zum Zitat van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99:550–7.CrossRefPubMed van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99:550–7.CrossRefPubMed
16.
Zurück zum Zitat Yu H, Joh YG, Son GM, Kim HS, Jo HJ, Kim HY. Distribution and impact of the visceral fat area in patients with colorectal cancer. Ann Coloproctol. 2016;32:20–6.CrossRefPubMedPubMedCentral Yu H, Joh YG, Son GM, Kim HS, Jo HJ, Kim HY. Distribution and impact of the visceral fat area in patients with colorectal cancer. Ann Coloproctol. 2016;32:20–6.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Jones KI, Doleman B, Scott S, Lund JN, Williams JP. Simple psoas cross-sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications. Colorectal Dis. 2015;17:O20–26.CrossRefPubMed Jones KI, Doleman B, Scott S, Lund JN, Williams JP. Simple psoas cross-sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications. Colorectal Dis. 2015;17:O20–26.CrossRefPubMed
18.
Zurück zum Zitat Margadant CC, Bruns ER, Sloothaak DA, et al. Lower muscle density is associated with major postoperative complications in older patients after surgery for colorectal cancer. Eur J Surg Oncol. 2016;42:1654–9.CrossRefPubMed Margadant CC, Bruns ER, Sloothaak DA, et al. Lower muscle density is associated with major postoperative complications in older patients after surgery for colorectal cancer. Eur J Surg Oncol. 2016;42:1654–9.CrossRefPubMed
19.
Zurück zum Zitat Cecchini S, Cavazzini E, Marchesi F, Sarli L, Roncoroni L. Computed tomography volumetric fat parameters versus body mass index for predicting short-term outcomes of colon surgery. World J Surg. 2011;35:415–23.CrossRefPubMed Cecchini S, Cavazzini E, Marchesi F, Sarli L, Roncoroni L. Computed tomography volumetric fat parameters versus body mass index for predicting short-term outcomes of colon surgery. World J Surg. 2011;35:415–23.CrossRefPubMed
20.
Zurück zum Zitat Chen B, Zhang Y, Zhao S, et al. The impact of general/visceral obesity on completion of mesorectum and perioperative outcomes of laparoscopic TME for rectal cancer: a STARD-compliant article. Medicine. 2016;95:e4462.CrossRefPubMedPubMedCentral Chen B, Zhang Y, Zhao S, et al. The impact of general/visceral obesity on completion of mesorectum and perioperative outcomes of laparoscopic TME for rectal cancer: a STARD-compliant article. Medicine. 2016;95:e4462.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Heus C, Cakir H, Lak A, Doodeman HJ, Houdijk AP. Visceral obesity, muscle mass, and outcome in rectal cancer surgery after neoadjuvant chemoradiation. Int J Surg. 2016;29:159–64.CrossRefPubMed Heus C, Cakir H, Lak A, Doodeman HJ, Houdijk AP. Visceral obesity, muscle mass, and outcome in rectal cancer surgery after neoadjuvant chemoradiation. Int J Surg. 2016;29:159–64.CrossRefPubMed
22.
Zurück zum Zitat Huang DD, Wang SL, Zhuang CL, et al. Sarcopenia, as defined by low muscle mass, strength, and physical performance, predicts complications after surgery for colorectal cancer. Colorectal Dis. 2015;17:O256–64.CrossRefPubMed Huang DD, Wang SL, Zhuang CL, et al. Sarcopenia, as defined by low muscle mass, strength, and physical performance, predicts complications after surgery for colorectal cancer. Colorectal Dis. 2015;17:O256–64.CrossRefPubMed
23.
Zurück zum Zitat Park BK, Park JW, Ryoo SB, Jeong SY, Park KJ, Park JG. Effect of visceral obesity on surgical outcomes of patients undergoing laparoscopic colorectal surgery. World J Surg. 2015;39:2343–53.CrossRefPubMed Park BK, Park JW, Ryoo SB, Jeong SY, Park KJ, Park JG. Effect of visceral obesity on surgical outcomes of patients undergoing laparoscopic colorectal surgery. World J Surg. 2015;39:2343–53.CrossRefPubMed
24.
Zurück zum Zitat Scott SI, Farid S, Mann C, Jones R, Kang P, Evans J. Abdominal fat ratio: a novel parameter for predicting conversion in laparoscopic colorectal surgery. Ann R Coll Surg Engl. 2017;99:46–50.CrossRefPubMedPubMedCentral Scott SI, Farid S, Mann C, Jones R, Kang P, Evans J. Abdominal fat ratio: a novel parameter for predicting conversion in laparoscopic colorectal surgery. Ann R Coll Surg Engl. 2017;99:46–50.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, et al. Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results From the C SCANS study. JAMA Oncol. 2017;3:e172319.CrossRef Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, et al. Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results From the C SCANS study. JAMA Oncol. 2017;3:e172319.CrossRef
26.
Zurück zum Zitat Chen WZ, Chen XD, Ma LL, et al. Impact of visceral obesity and sarcopenia on short-term outcomes after colorectal cancer surgery. Dig Dis Sci. 2018;63:1620–30.CrossRefPubMed Chen WZ, Chen XD, Ma LL, et al. Impact of visceral obesity and sarcopenia on short-term outcomes after colorectal cancer surgery. Dig Dis Sci. 2018;63:1620–30.CrossRefPubMed
27.
Zurück zum Zitat Hanaoka M, Yasuno M, Ishiguro M, et al. Morphologic change of the psoas muscle as a surrogate marker of sarcopenia and predictor of complications after colorectal cancer surgery. Int J Colorectal Dis. 2017;32:847–56.CrossRefPubMed Hanaoka M, Yasuno M, Ishiguro M, et al. Morphologic change of the psoas muscle as a surrogate marker of sarcopenia and predictor of complications after colorectal cancer surgery. Int J Colorectal Dis. 2017;32:847–56.CrossRefPubMed
28.
Zurück zum Zitat Nakanishi R, Oki E, Sasaki S, et al. Sarcopenia is an independent predictor of complications after colorectal cancer surgery. Surg Today. 2017;48:151–7.CrossRefPubMed Nakanishi R, Oki E, Sasaki S, et al. Sarcopenia is an independent predictor of complications after colorectal cancer surgery. Surg Today. 2017;48:151–7.CrossRefPubMed
29.
Zurück zum Zitat van der Kroft G, Bours D, Janssen-Heijnen DM, van Berlo D, Konsten D. Value of sarcopenia assessed by computed tomography for the prediction of postoperative morbidity following oncological colorectal resection: a comparison with the malnutrition screening tool. Clin Nutr. 2018;24:114–9. van der Kroft G, Bours D, Janssen-Heijnen DM, van Berlo D, Konsten D. Value of sarcopenia assessed by computed tomography for the prediction of postoperative morbidity following oncological colorectal resection: a comparison with the malnutrition screening tool. Clin Nutr. 2018;24:114–9.
30.
Zurück zum Zitat Womer AL, Brady JT, Kalisz K, et al. Do psoas muscle area and volume correlate with postoperative complications in patients undergoing rectal cancer resection? Am J Surg. 2018;215:503–6.CrossRefPubMed Womer AL, Brady JT, Kalisz K, et al. Do psoas muscle area and volume correlate with postoperative complications in patients undergoing rectal cancer resection? Am J Surg. 2018;215:503–6.CrossRefPubMed
31.
Zurück zum Zitat Hopkins JJ, Skubleny D, Bigam DL, Baracos VE, Eurich DT, Sawyer MB. Barriers to the interpretation of body composition in colorectal cancer: a review of the methodological inconsistency and complexity of the CT-defined body habitus. Ann Surg Oncol. 2018;25:1381–94.CrossRefPubMed Hopkins JJ, Skubleny D, Bigam DL, Baracos VE, Eurich DT, Sawyer MB. Barriers to the interpretation of body composition in colorectal cancer: a review of the methodological inconsistency and complexity of the CT-defined body habitus. Ann Surg Oncol. 2018;25:1381–94.CrossRefPubMed
32.
Zurück zum Zitat Baracos VE. Psoas as a sentinel muscle for sarcopenia: a flawed premise. J Cachexia Sarcopenia Muscle. 2017;8:527–8. Baracos VE. Psoas as a sentinel muscle for sarcopenia: a flawed premise. J Cachexia Sarcopenia Muscle. 2017;8:527–8.
33.
Zurück zum Zitat Rutten IJG, Ubachs J, Kruitwagen R, Beets-Tan RGH, Olde Damink SWM, Van Gorp T. Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer. J Cachexia Sarcopenia Muscle. 2017;8:630–8.CrossRefPubMedPubMedCentral Rutten IJG, Ubachs J, Kruitwagen R, Beets-Tan RGH, Olde Damink SWM, Van Gorp T. Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer. J Cachexia Sarcopenia Muscle. 2017;8:630–8.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Simonsen C, de Heer P, Bjerre ED, et al. Sarcopenia and postoperative complication risk in gastrointestinal surgical oncology: a meta-analysis. Ann Surg. 2018;268:58–69.PubMed Simonsen C, de Heer P, Bjerre ED, et al. Sarcopenia and postoperative complication risk in gastrointestinal surgical oncology: a meta-analysis. Ann Surg. 2018;268:58–69.PubMed
35.
Zurück zum Zitat Doyle SL, Bennett AM, Donohoe CL, et al. Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research. Nutr Res. 2013;33:171–9.CrossRefPubMed Doyle SL, Bennett AM, Donohoe CL, et al. Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research. Nutr Res. 2013;33:171–9.CrossRefPubMed
36.
Zurück zum Zitat Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629–35.CrossRefPubMed Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629–35.CrossRefPubMed
37.
Zurück zum Zitat Martin L. Diagnostic criteria for cancer cachexia: data versus dogma. Curr Opin Clin Nutr Metab Care. 2016;19:188–98.PubMed Martin L. Diagnostic criteria for cancer cachexia: data versus dogma. Curr Opin Clin Nutr Metab Care. 2016;19:188–98.PubMed
38.
Zurück zum Zitat Bye A, Sjoblom B, Wentzel-Larsen T, et al. Muscle mass and association to quality of life in non-small cell lung cancer patients. J Cachexia Sarcopenia Muscle. 2017;8:759–67.CrossRefPubMedPubMedCentral Bye A, Sjoblom B, Wentzel-Larsen T, et al. Muscle mass and association to quality of life in non-small cell lung cancer patients. J Cachexia Sarcopenia Muscle. 2017;8:759–67.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Kuk JL, Saunders TJ, Davidson LE, Ross R. Age-related changes in total and regional fat distribution. Ageing Res Rev. 2009;8:339–48.CrossRefPubMed Kuk JL, Saunders TJ, Davidson LE, Ross R. Age-related changes in total and regional fat distribution. Ageing Res Rev. 2009;8:339–48.CrossRefPubMed
40.
Zurück zum Zitat Rolland Y, Czerwinski S Fau-Abellan Van Kan G, Abellan Van Kan G Fau-Morley JE, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12:433–50. Rolland Y, Czerwinski S Fau-Abellan Van Kan G, Abellan Van Kan G Fau-Morley JE, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12:433–50.
41.
Zurück zum Zitat Kuchnia AJ, Teigen LM, Cole AJ, et al. Phase angle and impedance ratio: reference cut-points from the United States National Health and Nutrition Examination Survey 1999–2004 From Bioimpedance Spectroscopy Data. J Parenter Enteral Nutr. 2017;41:1310–15.CrossRef Kuchnia AJ, Teigen LM, Cole AJ, et al. Phase angle and impedance ratio: reference cut-points from the United States National Health and Nutrition Examination Survey 1999–2004 From Bioimpedance Spectroscopy Data. J Parenter Enteral Nutr. 2017;41:1310–15.CrossRef
42.
43.
Zurück zum Zitat Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107:931–6.CrossRefPubMedPubMedCentral Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107:931–6.CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Du Y, Karvellas CJ, Baracos V, et al. Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery. Surgery. 2014;156:521–7.CrossRefPubMed Du Y, Karvellas CJ, Baracos V, et al. Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery. Surgery. 2014;156:521–7.CrossRefPubMed
45.
Zurück zum Zitat Nelson G, Kiyang LN, Crumley ET, et al. Implementation of enhanced recovery after surgery (ERAS) across a provincial healthcare system: the ERAS Alberta Colorectal Surgery Experience. World J Surg. 2016;40:1092–103.CrossRefPubMed Nelson G, Kiyang LN, Crumley ET, et al. Implementation of enhanced recovery after surgery (ERAS) across a provincial healthcare system: the ERAS Alberta Colorectal Surgery Experience. World J Surg. 2016;40:1092–103.CrossRefPubMed
47.
Zurück zum Zitat Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33:997–1006.CrossRefPubMed Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33:997–1006.CrossRefPubMed
48.
Zurück zum Zitat Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85:1–10.CrossRefPubMedPubMedCentral Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85:1–10.CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat van der Werf A, Dekker IM, Meijerink MR, Wierdsma NJ, de van der Schueren MAE, Langius JAE. Skeletal muscle analyses: agreement between non-contrast and contrast CT scan measurements of skeletal muscle area and mean muscle attenuation. Clin Physiol Funct Imaging. 2017;38:366–72.CrossRefPubMed van der Werf A, Dekker IM, Meijerink MR, Wierdsma NJ, de van der Schueren MAE, Langius JAE. Skeletal muscle analyses: agreement between non-contrast and contrast CT scan measurements of skeletal muscle area and mean muscle attenuation. Clin Physiol Funct Imaging. 2017;38:366–72.CrossRefPubMed
51.
Zurück zum Zitat Weaver BW, Wuensch K.L. SPSS and SAS programs for comparing Pearson correlations and OLS regression coefficients. Behav Res Methods. 2013;45:880–95. Weaver BW, Wuensch K.L. SPSS and SAS programs for comparing Pearson correlations and OLS regression coefficients. Behav Res Methods. 2013;45:880–95.
52.
Zurück zum Zitat Austin P. A comparison of statistical modeling strategies for analyzing length of stay after CABG surgery. Health Serv Outcomes Res Methodol. 2003;3:107–33.CrossRef Austin P. A comparison of statistical modeling strategies for analyzing length of stay after CABG surgery. Health Serv Outcomes Res Methodol. 2003;3:107–33.CrossRef
54.
Zurück zum Zitat Xiao J, Caan BJ, Weltzien E, et al. Associations of preexisting comorbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer. J Cachexia Sarcopenia Muscle. 2018 https://doi.org/10.1002/jcsm.12301. Retrieved online 19 April 2018. Xiao J, Caan BJ, Weltzien E, et al. Associations of preexisting comorbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer. J Cachexia Sarcopenia Muscle. 2018 https://​doi.​org/​10.​1002/​jcsm.​12301. Retrieved online 19 April 2018.
55.
Zurück zum Zitat Malietzis G, Johns N, Al-Hassi HO, et al. Low muscularity and myosteatosis is related to the host systemic inflammatory response in patients undergoing surgery for colorectal cancer. Ann Surg. 2016;263:320–5.CrossRefPubMed Malietzis G, Johns N, Al-Hassi HO, et al. Low muscularity and myosteatosis is related to the host systemic inflammatory response in patients undergoing surgery for colorectal cancer. Ann Surg. 2016;263:320–5.CrossRefPubMed
56.
Zurück zum Zitat Lohsiriwat V, Pongsanguansuk W, Lertakyamanee N, Lohsiriwat D. Impact of metabolic syndrome on the short-term outcomes of colorectal cancer surgery. Dis Colon Rectum. 2010;53:186–91.CrossRefPubMed Lohsiriwat V, Pongsanguansuk W, Lertakyamanee N, Lohsiriwat D. Impact of metabolic syndrome on the short-term outcomes of colorectal cancer surgery. Dis Colon Rectum. 2010;53:186–91.CrossRefPubMed
57.
Zurück zum Zitat Carli F, Gillis C, Scheede-Bergdahl C. Promoting a culture of prehabilitation for the surgical cancer patient. Acta Oncol. 2017;56:128–33.CrossRefPubMed Carli F, Gillis C, Scheede-Bergdahl C. Promoting a culture of prehabilitation for the surgical cancer patient. Acta Oncol. 2017;56:128–33.CrossRefPubMed
Metadaten
Titel
Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach
verfasst von
Lisa Martin, MSc, RD
Jessica Hopkins, MD
Georgios Malietzis, PhD, MD
J. T. Jenkins, MD
Michael B. Sawyer, MD
Ron Brisebois, MD
Anthony MacLean, MD
Gregg Nelson, PhD, MD
Leah Gramlich, MD
Vickie E. Baracos, PhD
Publikationsdatum
13.07.2018
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 9/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6652-x

Weitere Artikel der Ausgabe 9/2018

Annals of Surgical Oncology 9/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.